A systematic literature review published in 2010 [ 14] indicated that treatment strategies leading to maintenance of physical function and keeping patients at work are cost effective, even when including more-costly biologic agents.
Ranibizumab was cost effective even when assuming 12 ranibizumab injections in the first year (NMB, £596) and only ceased to be cost effective if 11 or more injections were administered in year 2, or at a cost over £1,100 per monitoring visit or a cost over £1,300 per injection visit at the base case number of injections.
The sponsor, Novartis, asserts that the new treatment will be cost-effective, even when priced between $4 and $5 million per patient.
The scheme should be cost-effective even when the content of the sequence of broadcast messages is not known in its entirety before hand by the base station.
A universal strategy to promote healthy diet through brief intervention in primary care is unlikely to be cost-effective, even when delivered at low unit cost.
It is reasonable to assume that some interventions, especially those provided by volunteers, could be cost-effective – even when no superior clinical results could be demonstrated.
Active case finding programs in Cambodia and similar epidemiologic and socioeconomic settings can be cost-effective even when considering direct health benefits to the patients alone, and irrespective of the impact on further transmission.
Our model predicted that smoking cessation was cost-effective even when only its impact on macular degeneration and mortality were considered.
Vaccination of boys was not found to be cost-effective, even for additional scenarios with very low vaccine or program administration costs – only when combined vaccine and administration costs were NZ$125 or lower per dose was vaccination of boys cost-effective.
An intervention can therefore be cost-effective even if it costs more.
Vaccination of girls against high-risk HPV is relatively cost effective even when vaccine efficacy is low.
